Zdrowie i gospodarka · 24/08/2018
FDA Releases Draft Guidance on Placebos and Blinding in Cancer Clinical Trials
The FDA has released a draft guidance for industry on the use of placebos and blinding in clinical trials for cancer treatments, focusing on hematologic malignancies and oncologic diseases.